It's the second year in a row that Medicare will negotiate drug prices after the Inflation Reduction Act authorized it to do so in 2022. Blockbuster weight loss drug Ozempic could get cheaper by 2027, ...

The Centers for Medicare & Medicaid Services wants to lower the cost for 15 more drugs including Ozempic and Wegovy.

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities, federal health officials announced in a news release.

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

On its last weekday in power, the Biden Administration has chosen the next batch of drugs up for price negotiation in ...

Novo sells semaglutide as Ozempic, Rybelsus and Wegovy. The CMS will treat the different forms as a single product in price ...

IRA has unintended consequences on investment landscape for small- and large-molecule drugs stifling the development of new ...

Ozempic and Wegovy ... that it “remains opposed to government price setting through the IRA (Inflation Reduction Act) and has significant concerns about how the law is being implemented by ...

Millions of Part D patients who rely on price-controlled drugs will see their out-of-pocket medication costs increase.

To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...

Novo Nordisk (NVO), a pharmaceutical company, isn’t too worried about the U.S. government’s plan to negotiate prices for its ...

Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...